Renal cancer paradox: Higher incidence but not higher mortality among African-Americans

European Journal of Cancer Prevention

Volumn 20, Issue 4, 2011, Pages 331-333

  Lipworth, Loren ^a,b   McLaughlin, Joseph K ^a,b   Tarone, Robert E ^a,b   Blot, William J ^a,b  

^a INTERNATIONAL EPIDEMIOLOGY INSTITUTE   (United States)

^b VANDERBILT INGRAM CANCER CENTER   (United States)

Author keywords

incidence; mortality; nephrectomy; racial differences; renal cell cancer

Indexed keywords

AFRICAN AMERICAN; AGE; ARTICLE; CANCER INCIDENCE; CANCER MORTALITY; CANCER STAGING; FEMALE; HEALTH CARE ACCESS; HUMAN; INCIDENTAL FINDING; KIDNEY CANCER; MALE; NEPHRECTOMY; PRIORITY JOURNAL; RACE; SURVIVAL RATE;

AFRICAN AMERICANS; FEMALE; HUMANS; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; SEER PROGRAM; SURVIVAL RATE;

EID: 79958836491     PISSN: 09598278     EISSN: 14735709     Source Type: Journal    
DOI: 10.1097/CEJ.0b013e328345f9b3     Document Type: Article

References (12)

1. Berndt SI, Carter HB, Schoenberg MP, Newschaffer CJ (2007). Disparities in treatment and outcome for renal cell cancer among older black and white patients. J Clin Oncol 25:3589-3595. (Pubitemid 47372596)
2. Genovese G, Friedman DJ, Ross MD, Lecordier L, Uzureau P, Freedman BI, et al. (2010). Association of trypanolytic ApoL1 variants with kidney disease in African-Americans. Science 329:841-845.
3. Geronimus AT, Bound J, Waidmann TA, Hillemeier MM, Burns PB (1996). Excess mortality among blacks and whites in the United States. N Engl J Med 335:1552-1558. (Pubitemid 26384749)
4. Jemal A, Thun MJ, Ries LAG, Howe HL, Weir HK, Ceter MM, et al. (2008). Annual report to the nation on the status of cancer, 1975-2005, featuring trends in lung cancer, tobacco use, and tobacco control. J Natl Cancer Inst 100:1672-1694.
5. Kosary CL, McLaughlin JK (1993). Kidney and renal pelvis. In: Miller BA, Ries LAG, Hankey BF, Kosary CL, Harras A, Devesa SS, Edwards BK, editors. SEER cancer statistics review: 1973-1990. Bethesda, MD: National Cancer Institute. Department of Health and Human Services publication NIH 93-2789, Xl-X22.
6. Lipworth L, Tarone RE, McLaughlin JK (2006). The epidemiology of renal cell carcinoma. J Urol 176:2353-2358. (Pubitemid 44665976)
7. Mathew A, Devesa SS, Fraumeni JF Jr, Chow WH (2002). Global increases in kidney cancer incidence, 1973-1992. Eur J Cancer Prev 11:171-178. (Pubitemid 34478435)
8. National Cancer Institute (2009). DCCPS, Surveillance Research Program, Cancer Statistics Branch, Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) Research Data (1973-2007), based on the November 2008 submission.
9. Stafford HS, Saltzstein SL, Shimasaki S, Sanders C, Downs TM, Sadler GR (2008). Racial/ethnic and gender disparities in renal cell carcinoma incidence and survival. J Urol 179:1704-1708.
10. US Renal Data System, USRDS 2010 Annual Data Report. Atlas of end-stage renal disease in the United States. Bethesda, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2010. Available at: http://www.usrds.org/atlas.htm.
11. Vaishampayan N, Do H, Hussain M, Schwartz K (2003). Racial disparity in incidence patterns and outcome of kidney cancer. Urol 62:1012-1017. (Pubitemid 37510082)
12. Zini L, Perrotte P, Capitanio U, Jeldres C, Duclos A, Arjane P, et al. (2008). Race affects access to nephrectomy but not survival in renal cell carcinoma. BJU Int 103:889-893.